Cost Effectiveness and Resource Allocation

Papers
(The H4-Index of Cost Effectiveness and Resource Allocation is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness65
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?51
Prescription cost analysis and economic impact of drug treatment in patients with chronic illness, attending the medicine out-patient department in a tertiary care hospital at South Delhi30
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea29
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency29
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial28
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran27
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model24
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer23
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening21
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value21
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”20
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia20
Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan15
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis15
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study15
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique15
0.050456047058105